News
Pharmaresearch Products, accomplishment of overseas investment and joint development
17-05-19 17:54
영문ci.JPG

PharmaResearch Products has participated in the management of Swedish pharmaceutical company, Promore Pharma, by investing and stake acquisition for joint development of anti-adhesion medicine PXL01. Promore Pharma is currently promoting to list their company in Swedish stock market. PharmaReserach products is responsible for R&D investment and providing clinical samples and will obtain product license for the global market in near future.